Profil
Mr. Jamal El-Mosleh is a Chief Executive Officer at Elicera Therapeutics AB. Mr. El-Mosleh was previously employed as a Chief Executive Officer by Annexin Pharmaceuticals AB and a Chief Executive Officer & IR Contact by Immunicum AB. He also served on the board at Elypta AB. He received his graduate degree from Chalmers University of Technology and a graduate degree from Chalmers School of Entrepreneurship.
Aktive Positionen von Jamal El-Mosleh
| Unternehmen | Position | Beginn |
|---|---|---|
| ELICERA THERAPEUTICS AB | Vorstandsvorsitzender | 01.01.2020 |
Ehemalige bekannte Positionen von Jamal El-Mosleh
| Unternehmen | Position | Ende |
|---|---|---|
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Develops and operates software platform for artificial intelligence algorithms trained by our clinical database | Direktor/Vorstandsmitglied | 01.01.2020 |
| ANNEXIN PHARMACEUTICALS AB | Vorstandsvorsitzender | 01.01.2019 |
| MENDUS AB | Vorstandsvorsitzender | 01.10.2016 |
Ausbildung von Jamal El-Mosleh
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Chalmers University of Technology
Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mendus AB
Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Chalmers School of Entrepreneurship
Chalmers School of Entrepreneurship Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Annexin Pharmaceuticals AB
Annexin Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures drugs for cardiovascular diseases | Health Technology |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Develops and operates software platform for artificial intelligence algorithms trained by our clinical database | Technology Services |
Elicera Therapeutics AB
Elicera Therapeutics AB BiotechnologyHealth Technology Develops and trades cell and gene therapies in immune-oncology | Health Technology |
















